Diabetic monofilament tester for neuropathy

$14.00
(No reviews yet) Write a Review

Monofilament diabetes-10 gram Tester for diabetic neuropathy

with 25 refills professional quality (INCREDIBLE VALUE) 

 

About the product
  • Semmes weinstein monofilament made to exact specifications in an FDA approved facility
  • Calibrated to buckle at 10g of force to detect diabetic neuropathy on extremities such as the foot
  • Comes with 25 refills so this unit will last a very long time or for use in a healthcare professionals office
  • Portable and easy to store because monofilament retracts into the body of the unit
  • Incredible deal monofilaments can weaken over time so should be replaced to maintain accuracy. 25 replacements should last a very long time
 

Rapid Screening for Diabetic Neuropathy

Multiple screening methods are published. These methods are designed to screen for the presence or absence of diabetic neuropathy, as opposed to screening for specific sites on the feet that are at risk of ulceration (multisite testing). If neuropathy is identified by either of these methods, other sites may be tested to identify high-risk areas for ulceration.

Part A:

Rapid Screening for Diabetic Neuropathy Using the 10-g Semmes-Weinstein Monofilament

1.  Show the 10-g Semmes-Weinstein monofilament to the patient.
2.  Touch it first to the patient’s forehead or sternum so that the sensation is understood.
3.  Instruct the patient to say “yes” every time the monofilament stimulus is perceived.
4.  With the patient’s eyes closed, apply the monofilament to the dorsum of the great toe proximal to the nail bed as shown in the illustration below. Use a smooth motion-touch the skin, bend the filament for a full second, then lift from the skin.
5.  Perform this stimulus 4 times per foot in an arrhythmic manner so the patient does not anticipate when the stimulus is to be applied.
6.  For each of the 8 stimuli, assign a score of 0 if it is not perceived, 0.5 if it is substantially less than that perceived on the forehead or sternum, and 1 if it is perceived normally. A score of 3 out of 8 correct responses means that the presence of neuropathy is likely. A score of 3.5 to 5 means that the risk of new onset neuropathy in the next four years is high. A score of 5.5 or greater indicates that there is a low risk of neuropathy onset in the next four years.